Company intelligence / Profile preview

TriReme Medical

Pleasanton, California, United Statespharmaboardroom.com ↗

Ownership: Private
Employees: ~17
Development stage: Commercial

Overview

TriReme Medical develops and commercializes advanced minimally invasive devices for the treatment of complex vascular diseases. Its Chocolate Touch Drug-Coated Balloon received FDA premarket approval in February 2023 for treating peripheral artery disease. The company has a portfolio of patented technologies focused on improving outcomes in both peripheral and coronary interventions.

Therapeutic areas: Cardiovascular
Modalities: DeviceDrug-coated balloon
Industry: Surgical Medical Devices

Partnerships

MCRA Inc. assisted with regulatory strategy and FDA PMA submission for Chocolate Touch device.

Beyond the preview

Go deeper on TriReme Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TriReme Medical.

Explore the full profile